Coronary artery disease progression late after successful stent implantation

Journal of the American College of Cardiology

Volumn 59, Issue 9, 2012, Pages 793-799

  Zellweger, Michael J ^a   Kaiser, Christoph ^a   Jeger, Raban ^a   Brunner La Rocca, Hans Peter ^a,b   Buser, Peter ^a   Bader, Franziska ^a   Mueller Brand, Jan ^a   Pfisterer, Matthias ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

coronary artery disease; myocardial perfusion imaging; outcome research; percutaneous transluminal coronary angioplasty; stents

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; ARTICLE; BARE METAL STENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DISEASE COURSE; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAFETY; SURVIVAL RATE; TREATMENT RESPONSE;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; RETROSPECTIVE STUDIES; STENTS; SURVIVAL RATE; SWITZERLAND; TIME FACTORS;

EID: 84857271597     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.11.024     Document Type: Article

References (28)

1. W.K. Laskey, C.W. Yancy, W.H. Maisel Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 78, 2006 Circulation 115 2007 2352 2357
2. E.P. McFadden, E. Stabile, E. Regar Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521
3. M. Pfisterer, H.P. Brunner-La Rocca, P.T. Buser BASKET-LATE Investigators Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
4. B. Lagerqvist, S.K. James, U. Stenestrand, J. Lindback, T. Nilsson, L. Wallentin Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden N Engl J Med 356 2007 1009 1019
5. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
6. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
7. P. Wenaweser, J. Daemen, M. Zwahlen Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice 4-year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
8. A. Caixeta, M.B. Leon, A.J. Lansky 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents J Am Coll Cardiol 54 2009 894 902
9. S.G. Ellis, G.W. Stone, D.A. Cox TAXUS IV Investigators Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent) J Am Coll Cardiol Intv 2 2009 1248 1259
10. D.E. Cutlip, A.G. Chhabra, D.S. Baim Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials Circulation 110 2004 1226 1230
11. R. Chacko, M. Mulhearn, V. Novack Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting J Am Coll Cardiol Intv 2 2009 498 503
12. M.B. Leon, D.J. Allocco, K.D. Dawkins, D.S. Baim Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events J Am Coll Cardiol Intv 2 2009 504 512
13. C. Kaiser, H.P. Brunner-La Rocca, P.T. Buser BASKET Investigators Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitts Trial (BASKET) Lancet 366 2005 921 929
14. M. Pfisterer, H.P. Brunner-La Rocca, P. Rickenbacher BASKET Investigators Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET Eur Heart J 30 2009 16 24
15. M.J. Zellweger, C. Kaiser, H.P. Brunner-La Rocca BASKET Investigators Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation J Nucl Med 49 2008 550 556
16. T. Kimura, K. Abe, S. Shizuta Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries Circulation 105 2002 2986 2991
17. D.S. Berman, H. Kiat, J.D. Friedman Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study J Am Coll Cardiol 22 1993 1455 1464
18. F.J. Klocke, M.G. Baird, B.H. Lorell ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imagingexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) J Am Coll Cardiol 42 2003 1318 1333
19. R. Glaser, F. Selzer, D.P. Faxon Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention Circulation 111 2005 143 149
20. C. Kaiser, S. Galatius, P. Erne BASKET-PROVE Study Group Drug-eluting versus bare-metal stents in large coronary arteries N Engl J Med 363 2010 2310 2319
21. H.C. Wijeysundera, M. Machado, F. Farahati Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 19942005 JAMA 303 2010 1841 1847
22. A.A. Bavry, D.J. Kumbhani, A.N. Rassi, D.L. Bhatt, A.T. Askari Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials J Am Coll Cardiol 48 2006 1319 1325
23. E.C. Keeley, J.A. Boura, C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
24. A. Jeremias, S. Kaul, T.K. Rosengart, L. Gruberg, D.L. Brown The impact of revascularization on mortality in patients with nonacute coronary artery disease Am J Med 122 2009 152 161
25. M.E. Pfisterer, M.J. Zellweger, B.J. Gersh Management of stable coronary artery disease Lancet 375 2010 763 772
26. G.W. Stone, A. Maehara, A.J. Lansky PROSPECT Investigators A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235
27. M.J. Zellweger, M. Weinbacher, A.W. Zutter Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting J Am Coll Cardiol 42 2003 33 40
28. D.S. Berman, X. Kang, E.F. Schisterman Serial changes on quantitative myocardial perfusion SPECT in patients undergoing revascularization or conservative therapy J Nucl Cardiol 8 2001 428 437